138 related articles for article (PubMed ID: 15269134)
1. Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients.
Busch TM; Hahn SM; Wileyto EP; Koch CJ; Fraker DL; Zhang P; Putt M; Gleason K; Shin DB; Emanuele MJ; Jenkins K; Glatstein E; Evans SM
Clin Cancer Res; 2004 Jul; 10(14):4630-8. PubMed ID: 15269134
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia in human intraperitoneal and extremity sarcomas.
Evans SM; Hahn SM; Magarelli DP; Zhang PJ; Jenkins WT; Fraker DL; Hsi RA; McKenna WG; Koch CJ
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):587-96. PubMed ID: 11173159
[TBL] [Abstract][Full Text] [Related]
3. Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy.
Hahn SM; Putt ME; Metz J; Shin DB; Rickter E; Menon C; Smith D; Glatstein E; Fraker DL; Busch TM
Clin Cancer Res; 2006 Sep; 12(18):5464-70. PubMed ID: 17000681
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis.
Hahn SM; Fraker DL; Mick R; Metz J; Busch TM; Smith D; Zhu T; Rodriguez C; Dimofte A; Spitz F; Putt M; Rubin SC; Menon C; Wang HW; Shin D; Yodh A; Glatstein E
Clin Cancer Res; 2006 Apr; 12(8):2517-25. PubMed ID: 16638861
[TBL] [Abstract][Full Text] [Related]
5. Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy.
Menon C; Kutney SN; Lehr SC; Hendren SK; Busch TM; Hahn SM; Fraker DL
Clin Cancer Res; 2001 Dec; 7(12):3904-11. PubMed ID: 11751481
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.
Chitneni SK; Bida GT; Zalutsky MR; Dewhirst MW
J Nucl Med; 2014 Jul; 55(7):1192-7. PubMed ID: 24854792
[TBL] [Abstract][Full Text] [Related]
7. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts.
Lee J; Siemann DW; Koch CJ; Lord EM
Int J Cancer; 1996 Jul; 67(3):372-8. PubMed ID: 8707411
[TBL] [Abstract][Full Text] [Related]
8. Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].
Busch TM; Hahn SM; Evans SM; Koch CJ
Cancer Res; 2000 May; 60(10):2636-42. PubMed ID: 10825135
[TBL] [Abstract][Full Text] [Related]
9. EF5 binding and clinical outcome in human soft tissue sarcomas.
Evans SM; Fraker D; Hahn SM; Gleason K; Jenkins WT; Jenkins K; Hwang WT; Zhang P; Mick R; Koch CJ
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):922-7. PubMed ID: 16458778
[TBL] [Abstract][Full Text] [Related]
10. The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro.
Sadzuka Y; Tokutomi K; Iwasaki F; Sugiyama I; Hirano T; Konno H; Oku N; Sonobe T
Cancer Lett; 2006 Sep; 241(1):42-8. PubMed ID: 16303246
[TBL] [Abstract][Full Text] [Related]
11. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5.
Ziemer LS; Evans SM; Kachur AV; Shuman AL; Cardi CA; Jenkins WT; Karp JS; Alavi A; Dolbier WR; Koch CJ
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):259-66. PubMed ID: 12552344
[TBL] [Abstract][Full Text] [Related]
13. Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding.
Evans SM; Judy KD; Dunphy I; Jenkins WT; Nelson PT; Collins R; Wileyto EP; Jenkins K; Hahn SM; Stevens CW; Judkins AR; Phillips P; Geoerger B; Koch CJ
Cancer Res; 2004 Mar; 64(5):1886-92. PubMed ID: 14996753
[TBL] [Abstract][Full Text] [Related]
14. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma.
Cairns RA; Hill RP
Cancer Res; 2004 Mar; 64(6):2054-61. PubMed ID: 15026343
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia is important in the biology and aggression of human glial brain tumors.
Evans SM; Judy KD; Dunphy I; Jenkins WT; Hwang WT; Nelson PT; Lustig RA; Jenkins K; Magarelli DP; Hahn SM; Collins RA; Grady MS; Koch CJ
Clin Cancer Res; 2004 Dec; 10(24):8177-84. PubMed ID: 15623592
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.
Jenkins WT; Evans SM; Koch CJ
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1005-17. PubMed ID: 10705024
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
[TBL] [Abstract][Full Text] [Related]
18. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.
Evans SM; Jenkins WT; Joiner B; Lord EM; Koch CJ
Cancer Res; 1996 Jan; 56(2):405-11. PubMed ID: 8542599
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors.
Laughlin KM; Evans SM; Jenkins WT; Tracy M; Chan CY; Lord EM; Koch CJ
J Pharmacol Exp Ther; 1996 May; 277(2):1049-57. PubMed ID: 8627516
[TBL] [Abstract][Full Text] [Related]
20. An in vitro model to study cellular photosensitizer uptake and photodynamic dose-response relationships of tumor cells.
Leunig A; Staub F; Peters J; Heimann A; Kempski O; Goetz AE
Res Exp Med (Berl); 1993; 193(6):361-70. PubMed ID: 8122041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
